Unresolved questions in selection of therapies for treatment-naïve chronic lymphocytic leukemia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Unresolved questions in selection of therapies for treatment-naïve chronic lymphocytic leukemia ; volume:16 ; number:1 ; day:8 ; month:7 ; year:2023 ; pages:1-22 ; date:12.2023
Journal of hematology & oncology ; 16, Heft 1 (8.7.2023), 1-22, 12.2023
- Urheber
-
Bennett, Rory
Anderson, Mary Ann
Seymour, John F.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13045-023-01469-7
- URN
-
urn:nbn:de:101:1-2023101208532124691747
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bennett, Rory
- Anderson, Mary Ann
- Seymour, John F.
- SpringerLink (Online service)
Ähnliche Objekte (12)
High-Efficacy Therapies for Treatment-Naïve Individuals with Relapsing–Remitting Multiple Sclerosis
Response of treatment-naive brain metastases to stereotactic radiosurgery
Durability of pneumatic dilation monotherapy in treatment-naive achalasia patients
Cognitive Impairment In Treatment-Naïve Bipolar II and Unipolar Depression
Naturally occurring mutations to HCV protease inhibitors in treatment-naïve patients
Treatment-naïve idiopathic inflammatory myopathy: disease evaluation by fluorodeoxyglucose versus pyrophosphate
Benefit of [18F]-FDG PET/CT for treatment-naïve nasopharyngeal carcinoma
Intertumoral heterogeneity in patient-specific drug sensitivities in treatment-naïve glioblastoma
Immune profile and immunosurveillance in treatment-naive and neoadjuvantly treated esophageal adenocarcinoma
Fecal microbiome alterations in treatment-naive de novo Parkinson’s disease
Choroidal Thickness Changes After Intravitreal Aflibercept Injections in Treatment-Naïve Neovascular AMD
Integrated single-cell transcriptomics of cerebrospinal fluid cells in treatment-naïve multiple sclerosis
High-Efficacy Therapies for Treatment-Naïve Individuals with Relapsing–Remitting Multiple Sclerosis
Response of treatment-naive brain metastases to stereotactic radiosurgery
Durability of pneumatic dilation monotherapy in treatment-naive achalasia patients
Cognitive Impairment In Treatment-Naïve Bipolar II and Unipolar Depression
Naturally occurring mutations to HCV protease inhibitors in treatment-naïve patients
Treatment-naïve idiopathic inflammatory myopathy: disease evaluation by fluorodeoxyglucose versus pyrophosphate
Benefit of [18F]-FDG PET/CT for treatment-naïve nasopharyngeal carcinoma
Intertumoral heterogeneity in patient-specific drug sensitivities in treatment-naïve glioblastoma
Immune profile and immunosurveillance in treatment-naive and neoadjuvantly treated esophageal adenocarcinoma
Fecal microbiome alterations in treatment-naive de novo Parkinson’s disease
Choroidal Thickness Changes After Intravitreal Aflibercept Injections in Treatment-Naïve Neovascular AMD
Integrated single-cell transcriptomics of cerebrospinal fluid cells in treatment-naïve multiple sclerosis
High-Efficacy Therapies for Treatment-Naïve Individuals with Relapsing–Remitting Multiple Sclerosis
Response of treatment-naive brain metastases to stereotactic radiosurgery
Durability of pneumatic dilation monotherapy in treatment-naive achalasia patients
Cognitive Impairment In Treatment-Naïve Bipolar II and Unipolar Depression
Naturally occurring mutations to HCV protease inhibitors in treatment-naïve patients
Treatment-naïve idiopathic inflammatory myopathy: disease evaluation by fluorodeoxyglucose versus pyrophosphate
Benefit of [18F]-FDG PET/CT for treatment-naïve nasopharyngeal carcinoma
Intertumoral heterogeneity in patient-specific drug sensitivities in treatment-naïve glioblastoma
Immune profile and immunosurveillance in treatment-naive and neoadjuvantly treated esophageal adenocarcinoma
Fecal microbiome alterations in treatment-naive de novo Parkinson’s disease
Choroidal Thickness Changes After Intravitreal Aflibercept Injections in Treatment-Naïve Neovascular AMD